Gross Profit: Revenues from operations less the associated costs.
Alaunos Therapeutics, Inc. (TCRT) had Gross Profit of $0.01M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.01M |
|
$-35.14M |
|
-- |
|
|
Gross Profit |
$0.01M |
$34.27M |
|
$-34.27M |
|
$-0.87M |
|
$-35.14M |
|
$-35.14M |
|
$-35.14M |
|
$-35.14M |
|
$-35.14M |
|
$-35.14M |
|
$-34.27M |
|
$-30.61M |
|
15.99M |
|
15.99M |
|
$-2.20 |
|
$-2.20 |
|
| Balance Sheet Financials | |
$8.26M |
|
$0.00M |
|
$0.00M |
|
$8.26M |
|
$1.96M |
|
-- |
|
-- |
|
$1.96M |
|
$6.31M |
|
$6.31M |
|
$6.31M |
|
16.01M |
|
| Cash Flow Statement Financials | |
$-30.14M |
|
$1.35M |
|
$-18.14M |
|
$53.00M |
|
$6.06M |
|
$-46.93M |
|
$2.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-685340.00% |
|
-685340.00% |
|
-612260.00% |
|
-702800.00% |
|
-702800.00% |
|
$-28.80M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-557.16% |
|
-557.16% |
|
-425.27% |
|
-557.16% |
|
$0.39 |
|
$-1.80 |
|
$-1.88 |
|